S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.23 (-0.47%)
AAPL   137.19 (-0.12%)
MSFT   252.40 (-0.29%)
FB   193.33 (+1.07%)
GOOGL   2,176.49 (-1.41%)
AMZN   2,152.51 (+0.29%)
TSLA   660.00 (-6.97%)
NVDA   166.68 (-2.66%)
BABA   86.90 (-0.90%)
NIO   16.50 (-0.96%)
AMD   93.38 (-3.40%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.42 (+1.04%)
GE   75.30 (-0.58%)
F   12.46 (-3.04%)
DIS   102.25 (-0.86%)
AMC   12.19 (-6.80%)
PFE   52.52 (+3.69%)
PYPL   80.78 (-0.62%)
NFLX   185.78 (+1.25%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.23 (-0.47%)
AAPL   137.19 (-0.12%)
MSFT   252.40 (-0.29%)
FB   193.33 (+1.07%)
GOOGL   2,176.49 (-1.41%)
AMZN   2,152.51 (+0.29%)
TSLA   660.00 (-6.97%)
NVDA   166.68 (-2.66%)
BABA   86.90 (-0.90%)
NIO   16.50 (-0.96%)
AMD   93.38 (-3.40%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.42 (+1.04%)
GE   75.30 (-0.58%)
F   12.46 (-3.04%)
DIS   102.25 (-0.86%)
AMC   12.19 (-6.80%)
PFE   52.52 (+3.69%)
PYPL   80.78 (-0.62%)
NFLX   185.78 (+1.25%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.23 (-0.47%)
AAPL   137.19 (-0.12%)
MSFT   252.40 (-0.29%)
FB   193.33 (+1.07%)
GOOGL   2,176.49 (-1.41%)
AMZN   2,152.51 (+0.29%)
TSLA   660.00 (-6.97%)
NVDA   166.68 (-2.66%)
BABA   86.90 (-0.90%)
NIO   16.50 (-0.96%)
AMD   93.38 (-3.40%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.42 (+1.04%)
GE   75.30 (-0.58%)
F   12.46 (-3.04%)
DIS   102.25 (-0.86%)
AMC   12.19 (-6.80%)
PFE   52.52 (+3.69%)
PYPL   80.78 (-0.62%)
NFLX   185.78 (+1.25%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.23 (-0.47%)
AAPL   137.19 (-0.12%)
MSFT   252.40 (-0.29%)
FB   193.33 (+1.07%)
GOOGL   2,176.49 (-1.41%)
AMZN   2,152.51 (+0.29%)
TSLA   660.00 (-6.97%)
NVDA   166.68 (-2.66%)
BABA   86.90 (-0.90%)
NIO   16.50 (-0.96%)
AMD   93.38 (-3.40%)
CGC   5.52 (-5.96%)
MU   68.92 (-0.69%)
T   20.42 (+1.04%)
GE   75.30 (-0.58%)
F   12.46 (-3.04%)
DIS   102.25 (-0.86%)
AMC   12.19 (-6.80%)
PFE   52.52 (+3.69%)
PYPL   80.78 (-0.62%)
NFLX   185.78 (+1.25%)

Procter & Gamble is a Hold For Now But Look to Buy in the Second Half

Wednesday, January 19, 2022 | Chris Markoch
Procter & Gamble is a Hold For Now But Look to Buy in the Second Half

Growth for the consumer staples giant is a question of when, not if 

Procter & Gamble (NYSE:PG) is down about 4% in the first weeks of 2021. Still, the stock is sitting on the high-end of its 52-week range. And with the company set to report earnings on January 19, it’s time to wonder if this is just a necessary consolidation, or the start of a larger sell-off.  

I like to remind investors that, in many cases, when a company tells you something (good or bad) you should generally pay attention. So it was that Procter & Gamble told investors on the company’s last earnings call that earnings were likely to be under pressure in the first half of its fiscal year (which began last quarter).  

Sure enough, P&G reported quarterly earnings of $1.61. While this was a 42% sequential increase in what is typically one of the company's strongest quarters, it was a 1% year-over-year decline from the $1.63 per share it posted in 2020. Furthermore, the earnings number only beat analysts’ projections by 1% whereas it had posted an 8.6% beat in the prior year. 

However, P&G is having no such issues on the top line where revenue came in at a record high of $20.34 billion. But here again, it’s important to pay attention to what the company is forecasting. In the fiscal year that ended in June, the company reported 6% organic growth.  

Like many consumer staples companies, Procter & Gamble is facing higher supply chain costs that it is passing along in part to end consumers. Those price increases have already started being seeded in the market. And so far the company is optimistic in their ability to come in at the high end of a 2% to 4% range.  


Nevertheless, it’s clear that the company is already managing expectations for slower growth. Which brings the stock price into question. As I pointed out above, PG stock is currently trading near the upper end of its 52-week range. And most of that growth has occurred since October 2021.  

Look for Growth in the Second Half of the Year 

While the company did forecast a sluggish start to the year, it also forecast earnings momentum to pick up in the second half of the year. Of course, investors are still on edge about the effect that higher interest rates will have on consumer spending and economic growth. However, as a defensive stock, Procter & Gamble is likely to weather any downturn more asily than other companies. 

This may be what was on the mind of JPMorgan (NYSE:JPM) analyst Andrea Faria Teixeira who reaffirmed a Buy rating for PG stock with a price target of $165.32 - over 10% higher than the consensus of the analysts that MarketBeat tracks.  

 The Dividend Makes PG Stock a Staple for Income Investors 

One strength of a stock like Procter & Gamble is the company’s ability to pay a reliable, and growing, dividend. In fact, Procter & Gamble is part of the exclusive Dividend Kings club. This is reserved for companies that have increased their dividend for at least 50 consecutive years. P&G has done so for 65 years.  

The company announced its most recent dividend will be paid out on February 15 and the ex-dividend date is January 20, 2022. That’s the day after earnings so I expect that investors who are looking to buy PG stock at a bargain price may be well served to wait until after the ex-dividend date passes. 

And if you currently own the stock, there is no reason to sell now. While you may not get the kind of stock price appreciation you got in 2021, the company is still planning to pay over $8 billion in dividends in FY 2022 with an additional $7 to $9 billion in share repurchases.  

 

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Procter & Gamble (PG)
2.9653 of 5 stars
$141.79+0.1%2.57%24.75Buy$165.64
Compare These Stocks  Add These Stocks to My Watchlist 

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.